$184 Million is the total value of Blue Water Life Science Advisors, LP's 9 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 90.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GH | Buy | GUARDANT HEALTH INC | $33,649,000 | -23.2% | 834,145 | +26.1% | 18.28% | -12.1% |
| NTRA | Sell | NATERA INC | $32,944,000 | -28.2% | 929,581 | -17.6% | 17.89% | -17.8% |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $27,046,000 | +17.8% | 2,104,785 | +0.8% | 14.69% | +34.8% |
| ADPT | New | ADAPTIVE BIOTECHNOLOGIES COR | $25,244,000 | – | 3,120,434 | +100.0% | 13.71% | – |
| New | CYTEK BIOSCIENCES INC | $22,533,000 | – | 2,100,000 | +100.0% | 12.24% | – | |
| BRKR | New | BRUKER CORP | $16,192,000 | – | 258,000 | +100.0% | 8.79% | – |
| TECH | New | BIO-TECHNE CORP | $16,119,000 | – | 46,500 | +100.0% | 8.75% | – |
| CDNA | Sell | CAREDX INC | $5,919,000 | -84.4% | 275,551 | -73.1% | 3.22% | -82.1% |
| SOMALOGIC INC | $4,484,000 | -43.6% | 992,086 | 0.0% | 2.44% | -35.5% | ||
| Exit | PEAR THERAPEUTICS INC | $0 | – | -194,686 | -100.0% | -0.47% | – | |
| OLK | Exit | OLINK HLDG ABsponsored ads | $0 | – | -210,439 | -100.0% | -1.76% | – |
| Exit | GINKGO BIOWORKS HOLDINGS INC | $0 | – | -1,781,684 | -100.0% | -3.41% | – | |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -211,917 | -100.0% | -7.65% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -2,660,000 | -100.0% | -11.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NATERA INC | 12 | Q3 2023 | 33.3% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 21.3% |
| AKOYA BIOSCIENCES INC | 8 | Q3 2023 | 23.4% |
| ADAPTIVE BIOTECHNOLOGIES COR | 8 | Q3 2023 | 17.7% |
| CAREDX INC | 7 | Q2 2022 | 19.0% |
| THERMO FISHER SCIENTIFIC INC | 5 | Q4 2021 | 16.0% |
| MAXCYTE INC | 5 | Q3 2023 | 11.8% |
| BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
| SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
| CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-18 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.